The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2015

Filed:

Nov. 02, 2012
Applicant:

Keybioscience Ag, Stans, CH;

Inventors:

Nozer M. Mehta, Randolph, NJ (US);

William Stern, Tenally, NJ (US);

Amy M. Sturmer, Towaco, NJ (US);

Morten Asser Karsdal, Copenhagen, DK;

Kim Henriksen, Hillerod, DK;

Assignee:

KeyBioscience AG, Stans, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/23 (2006.01); A61P 3/04 (2006.01); C07K 5/00 (2006.01); C07K 14/585 (2006.01);
U.S. Cl.
CPC ...
C07K 14/585 (2013.01); A61K 38/23 (2013.01);
Abstract

A peptide having a sequence selected from SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17 and SEQ ID NO:18. Said peptide used for the treatment of type I diabetes, Type II diabetes, metabolic syndrome, or obesity, or of apetite suppression, or for mitigating insulin resistance, or for reducing an undesirably high fasting serum glucose level, or for reducing an undesirably high peak serum glucose level, or for reducing an undesirably high peak serum insulin level, or for reducing an undesirably large response to a glucose tolerance test.


Find Patent Forward Citations

Loading…